Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 3:47 pm Sale |
2024-12-31 | 13G | Entrada Therapeutics, Inc. TRDA |
Roche Finance Ltd | 2,569,115 6.900% |
-175,005 (-6.38%) |
Filing History |
| 2024-02-14 4:12 pm Sale |
2023-12-31 | 13G | Entrada Therapeutics, Inc. TRDA |
Roche Finance Ltd | 2,744,120 8.200% |
-69,405 (-2.47%) |
Filing History |
| 2023-11-07 5:16 pm Purchase |
2023-10-25 | 13G | Aligos Therapeutics, Inc. ALGS |
Roche Finance Ltd | 441,038 15.350% |
317,344 (+256.56%) |
Filing History |
| 2023-02-13 4:52 pm Sale |
2022-12-31 | 13G | Eloxx Pharmaceuticals, Inc. ELOX |
Roche Finance Ltd | 1,893 0.100% |
-123,080 (-98.49%) |
Filing History |
| 2023-02-13 4:49 pm Unchanged |
2022-12-31 | 13G | Jasper Therapeutics, Inc. JSPR |
Roche Finance Ltd | 462,461 4.200% |
0 (Unchanged) |
Filing History |
| 2022-02-14 06:20 am Purchase |
2021-12-31 | 13G | Tempest Therapeutics, Inc. TPST |
Roche Finance Ltd | 72,612 1.100% |
72,612 (New Position) |
Filing History |
| 2022-02-14 06:19 am Sale |
2021-12-31 | 13G | Vaxcyte, Inc. PCVX |
Roche Finance Ltd | 2,334,113 4.400% |
-253,641 (-9.80%) |
Filing History |
| 2022-02-14 06:19 am Purchase |
2021-12-31 | 13G | Entrada Therapeutics, Inc. TRDA |
Roche Finance Ltd | 2,813,525 9.000% |
2,813,525 (New Position) |
Filing History |
| 2022-02-14 06:18 am Sale |
2021-12-31 | 13G | Allakos Inc. ALLK |
Roche Finance Ltd | 2,629,157 4.800% |
-1,916,566 (-42.16%) |
Filing History |
| 2022-02-14 06:18 am Purchase |
2021-12-31 | 13G | Eloxx Pharmaceuticals, Inc. ELOX |
Roche Finance Ltd | 124,973 5.800% |
61,667 (+97.41%) |
Filing History |
| 2021-10-04 08:54 am Purchase |
2021-09-24 | 13G | Jasper Therapeutics, Inc. JSPR |
Roche Finance Ltd | 462,461 12.700% |
462,461 (New Position) |
Filing History |
| 2021-06-14 4:01 pm Purchase |
2021-04-01 | 13G | Eloxx Pharmaceuticals, Inc. ELOX |
Roche Finance Ltd | 63,307 5.300% |
63,307 (New Position) |
Filing History |
| 2021-03-02 4:15 pm Sale |
2021-02-26 | 13G | Senseonics Holdings, Inc. SENS |
Roche Finance Ltd | 17,523,209 4.700% |
-10,822,066 (-38.18%) |
Filing History |
| 2021-02-16 07:03 am Purchase |
2019-12-31 | 13G | Allakos Inc. ALLK |
Roche Finance Ltd | 4,545,723 9.300% |
1,766,566 (+63.56%) |
Filing History |
| 2021-02-16 07:03 am Purchase |
2020-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Roche Finance Ltd | 123,694 8.100% |
123,694 (New Position) |
Filing History |
| 2021-02-16 07:02 am Purchase |
2020-12-31 | 13G | PANDION THERAPEUTICS INC PAND |
Roche Finance Ltd | 3,086,084 10.500% |
3,086,084 (New Position) |
Filing History |
| 2021-02-16 07:02 am Purchase |
2020-12-31 | 13G | Vaxcyte, Inc. PCVX |
Roche Finance Ltd | 2,587,754 5.100% |
2,587,754 (New Position) |
Filing History |
| 2021-02-16 07:02 am Unchanged |
2020-12-31 | 13G | Millendo Therapeutics, Inc. MLND |
Roche Finance Ltd | 72,612 5.700% |
0 (Unchanged) |
Filing History |
| 2021-02-16 07:01 am Purchase |
2020-12-31 | 13G | Allakos Inc. ALLK |
Roche Finance Ltd | 2,779,157 5.300% |
2,779,157 (New Position) |
Filing History |
| 2021-02-16 07:01 am Purchase |
2020-12-31 | 13G | Senseonics Holdings, Inc. SENS |
Roche Finance Ltd | 28,345,275 11.500% |
28,345,275 (New Position) |
Filing History |